AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19828907
Drug: American ginseng
RxNorm normalized name: American ginseng
DrugBank: Panax quinquefolius whole (DB14296)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: American ginseng supplementation (500 mg daily for 4 months)
Trial: 16735951
Drug: Estradiol and
RxNorm normalized name: Estradiol and Norgestimate Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol and testosterone therapy
Trial: 16735951
Drug: No hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No hormone therapy (untreated postmenopausal women)
Trial: 8085692
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy plus radiation therapy
Trial: 8085692
Drug: Interferon combined
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon combined with psoralen plus ultraviolet A light therapy
Trial: 8085692
Drug: Photopheresis therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photopheresis therapy
Trial: 8085692
Drug: Interleukin-2 fusion
RxNorm normalized name: Anti-fap/interleukin-2 fusion protein ro6874281
DrugBank: Simlukafusp alfa (DB16092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin-2 fusion toxins and several antibody conjugates
Trial: 30470147
Drug: Gaviscon Double
RxNorm normalized name: Gaviscon
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gaviscon Double Action liquid (20 ml)
Trial: 25871803
Drug: Morphine exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine exposure
Trial: 23323867
Drug: Duodenal infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Duodenal infusion of donor feces after an initial vancomycin regimen (500 mg orally four times per day for 4 days) followed by bowel lavage and subsequent infusion.
Trial: 23323867
Drug: Standard vancomycin
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard vancomycin regimen (500 mg orally four times per day for 14 days).
Trial: 14709942
Drug: SRI treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRI treatment for 8 weeks
Trial: 11309437
Drug: Isotretinoin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin (30 mg/day) for 3 years
Trial: 7875957
Drug: Protirelin tartrate
RxNorm normalized name: PROTIRELIN
DrugBank: Protirelin (DB09421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Protirelin tartrate 4 mg/die i.m.
Trial: 31638960
Drug: Intravenous TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous TXA (1000 mg administered intravenously twice, just before surgery and 6 hours after)
Trial: 31638960
Drug: Combined TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined TXA (1000 mg of intra-articular TXA for each knee plus intravenous TXA as above)
Trial: 28577752
Drug: TR Band
RxNorm normalized name: Band-Aid Hurt-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TR Band hemostasis with 10 cc of air for 1.5 hours
Trial: 28577752
Drug: TR Band
RxNorm normalized name: Band-Aid Hurt-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TR Band hemostasis with 13 cc of air for 4 hours
Trial: 28577752
Drug: TR Band
RxNorm normalized name: Band-Aid Hurt-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TR Band hemostasis with 10 cc of air for 3 hours
Trial: 28577752
Drug: TR Band
RxNorm normalized name: Band-Aid Hurt-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TR Band hemostasis with 10 cc of air for 2 hours
Trial: 28577752
Drug: TR Band
RxNorm normalized name: Band-Aid Hurt-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TR Band hemostasis with less than 13 cc of air
Trial: 21231926
Drug: Interpersonal psychotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpersonal psychotherapy plus pharmacotherapy (IPT)
Trial: 21231926
Drug: Medication plus
RxNorm normalized name: salicylic acid Medicated Shampoo [Ionil Plus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication plus clinical management (CM)
Trial: 18436027
Drug: 4% articaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% articaine with 1:100,000 epinephrine buccal infiltration
Trial: 19228214
Drug: Buccal infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal infiltration with articaine
Trial: 22694755
Drug: Steroid-free (SF)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-free (SF) immunosuppression
Trial: 22694755
Drug: Steroid-based (SB)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-based (SB) immunosuppression
Trial: 12610738
Drug: Topical budesonide
RxNorm normalized name: budesonide Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical budesonide (10(‐2) g/ml to 10(‐8) g/ml)
Trial: 12610738
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (400 microg/day for 3 weeks)
Trial: 12610738
Drug: Overall dose-cutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall dose-cutaneous response effect
Trial: 527352
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg penbutolol twice daily
Trial: 30680400
Drug: Garlicin Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlicin Capsules 1/time, 3 times/d combined with Kangfuxin liquid 10 mL gargle 3 times/d
Trial: 30680400
Drug: Kangfuxin liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kangfuxin liquid 10 mL gargle 3 times/d
Trial: 30680400
Drug: Garlicin Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlicin Capsules combined with Kangfuxin liquid
Trial: 18759524
Drug: Prophylactic oral
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic oral metronidazole
Trial: 8776693
Drug: Nonsurgical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsurgical therapy (n = 24)
Trial: 6333298
Drug: Intracoronary streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary streptokinase followed by heparin
Trial: 6333298
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy with heparin
Trial: 25154829
Drug: Re-treatment Rituximab
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Re-treatment Rituximab (RR)
Trial: 22525771
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g of glucose (Glu)
Trial: 22525771
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g of galactose (Gal)
Trial: 16225492
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate 100 mg twice a day
Trial: 16225492
Drug: Iron-polymaltose complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-polymaltose complex 200 mg once a day
Trial: 16225492
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of treatments
Trial: 12419719
Drug: Diazepam 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 0.1 mg*kg(‐1) orally 60 min preoperatively (Group I)
Trial: 12419719
Drug: Diazepam 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 0.1 mg*kg(‐1) orally 90 min preoperatively (Group II)
Trial: 10365010
Drug: Levobupivacaine (0.25%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine (0.25% w/v 50 ml)
Trial: 10365010
Drug: Bupivacaine (0.25%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (0.25% w/v 50 ml)
Trial: 7574352
Drug: Fibrin glue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin glue (5 ml containing 500 IU of thrombin) applied by spray in the area of axillary dissection
Trial: 2340347
Drug: Sublingual administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual administration of vincamine
Trial: 2340347
Drug: Gastrointestinal absorption
RxNorm normalized name: ABSORPTION BASE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastrointestinal absorption of vincamine dissolved in saliva
Trial: 21305611
Drug: Placebo lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo lozenge (PL)
Trial: 22470104
Drug: DT cigarette
RxNorm normalized name: L-DT
DrugBank: Telbivudine (DB01265)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: DT cigarette administration
Trial: 10634020
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anesthesia (TIVA) with spontaneous breathing (Group 2)
Trial: 7044655
Drug: High-dose-aspirin/dipyridamole combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose-aspirin/dipyridamole combination (990 mg/day aspirin and 225 mg/day dipyridamole)
Trial: 7044655
Drug: Low-dose-aspirin/dipyridamole (330
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose-aspirin/dipyridamole (330 mg/day aspirin and 225 mg/day dipyridamole)
Trial: 7044655
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (990 mg/day)
Trial: 26364263
Drug: Daily combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily combined tenofovir disoproxil fumarate (245 mg) and emtricitabine (200 mg) immediately
Trial: 24333493
Drug: Prasugrel 10-mg
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 10-mg once-daily maintenance dose (with or without a 60-mg loading dose)
Trial: 24333493
Drug: Ticagrelor (continued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor (continued therapy)
Trial: 22315052
Drug: Novel care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel care pathway including diagnosis of 'diseased' QoL and up to five standardised treatments for specific QoL defects
Trial: 18571336
Drug: 3D radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3D radiation therapy (n = 29)
Trial: 18571336
Drug: 2D radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 2D radiation therapy (n = 38)
Trial: 17467138
Drug: Immersion in
RxNorm normalized name: OCTOCRYLENE 10 g in 100 g / HOMOSALATE 10 g in 100 g / AVOBENZONE 3 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [Eucerin Face immersive Hydration]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immersion in 0.1% (w/v) thymol-distilled water solution (24h)
Trial: 15965572
Drug: Device therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Device therapies
Trial: 9663818
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (slide show, weekly phone calls, calendar)
Trial: 7937285
Drug: Diltiazem 60
RxNorm normalized name: DILTIAZEM 60MG 12HR CAP,SA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 60 mg twice/day
Trial: 26578074
Drug: 3-day trimethoprim-sulfamethoxazole
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-day trimethoprim-sulfamethoxazole therapy
Trial: 26578074
Drug: 10-day trimethoprim-sulfamethoxazole
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day trimethoprim-sulfamethoxazole therapy
Trial: 24676964
Drug: C-MAP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-MAP plus treatment as usual (TAU)
Trial: 11856686
Drug: Eptifibatide (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eptifibatide (loading dose via intraarterial injection or IV)
Trial: 11856686
Drug: Eptifibatide (intraarterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eptifibatide (intraarterial loading dose)
Trial: 11856686
Drug: Control (rt-PA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (rt-PA and heparin only)
Trial: 7478776
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg aerosolized furosemide
Trial: 2303573
Drug: 10% potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% potassium nitrate glycerine-based gel
Trial: 2303573
Drug: glycerine gel
RxNorm normalized name: Glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: glycerine gel without potassium nitrate
Trial: 2303573
Drug: no gel
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: no gel and no treatment (control)
Trial: 6995134
Drug: Indomethacin 15
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin 15 mg t.i.d.
Trial: 6995134
Drug: Indomethacin 35
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin 35 mg t.i.d.
Trial: 6995134
Drug: Non-treatment periods
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-treatment periods
Trial: 28490871
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (optimized treatment)
Trial: 26228884
Drug: Intraventricular rtPA
RxNorm normalized name: cerliponase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraventricular rtPA treatment
Trial: 26228884
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no rtPA treatment)
Trial: 19440955
Drug: Nurse-administered propofol-alfentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-administered propofol-alfentanil sedation (NAPS)
Trial: 19126940
Drug: Oral Sildenafil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Sildenafil for 12 weeks
Trial: 1699982
Drug: Amiodarone (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (600 mg twice daily)
Trial: 68044
Drug: Aqueous ragweed
RxNorm normalized name: ethylcellulose aqueous dispersion type A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous ragweed extract (mean cumulative dose of 11.7 microng antigen E, equivalent to 4,180 PNU)
Trial: 68044
Drug: Aqueous ragweed
RxNorm normalized name: ethylcellulose aqueous dispersion type A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous ragweed extract (mean dose of 31.2 microng antigen E, equivalent to 11,140 PNU)
Trial: 30523765
Drug: Selu-metinib in
RxNorm normalized name: selumetinib
DrugBank: Selumetinib (DB11689)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selu-metinib in combination with dacarbazine
Trial: 26970181
Drug: Low-dose moderate-intensity
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose moderate-intensity aerobic exercise (150 min·week(‐1))
Trial: 26970181
Drug: High-dose moderate-intensity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose moderate-intensity aerobic exercise (300 min·week(‐1))
Trial: 20184577
Drug: UK-369,003 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK-369,003 100 mg modified release (MR)
Trial: 20184577
Drug: UK-369,003 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK-369,003 40 mg immediate release (IR)
Trial: 20184577
Drug: UK-369,003 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK-369,003 100 mg MR
Trial: 17578979
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg preoperatively and 200 mg every 12 h postoperatively
Trial: 11890384
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine, body therapy (somatic therapy, bodywork), and guided imagery for 6 months
Trial: 11890384
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine, body therapy, and guided imagery
Trial: 9567734
Drug: Stimulus control
RxNorm normalized name: Limulus polyphemus extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulus control treatment and withdrawal program (medicated participants)
Trial: 9567734
Drug: Stimulus control
RxNorm normalized name: Limulus polyphemus extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulus control treatment (nonmedicated participants)
Trial: 9567734
Drug: Stimulus control
RxNorm normalized name: Limulus polyphemus extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulus control treatment (medicated participants)
Trial: 7608644
Drug: Intra-uterine device,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-uterine device, condom, progestogen-only pill (alternative birth-control methods)
Trial: 2240632
Drug: Anesthesia including
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anesthesia including nitrous oxide (N2O) (50%-60%) during regional anesthesia supplemented with isoflurane and intravenous adjuvants
Trial: 2240632
Drug: Anesthesia excluding
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anesthesia excluding nitrous oxide (N2O) during regional anesthesia supplemented with isoflurane and intravenous adjuvants
Trial: 28851171
Drug: GnRH‐a (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH‐a (0.1 mg subcutaneous injection)
Trial: 28851171
Drug: Placebo (0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.9% saline 2 ml subcutaneous injection)
Trial: 23578980
Drug: Salbutamol nebulizer
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol nebulizer 1250 μg three times a day
Trial: 18650630
Drug: Standard parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard parenteral nutrition (n = 49)
Trial: 18650630
Drug: Immunomodulating parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunomodulating parenteral nutrition (n = 51)
Trial: 17312651
Drug: Metered Dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered Dose Inhaler with accessory device (MDI/AD)
Trial: 14552819
Drug: Impact of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Impact of 6MP dose on metabolite concentrations.
Trial: 15817423
Drug: Antiretroviral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral treatment (ART) interruptions for at least two weeks
Trial: 15817423
Drug: Treatment interruptions
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment interruptions (TI)
Trial: 10917355
Drug: Staged therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Staged therapy treating the entire volume to 10 Gy twice for AVMs with a volume of more than 25 cc
Trial: 1696438
Drug: Astemizole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astemizole (20 mg BID for three days)
Trial: 1696438
Drug: Placebo of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo of astemizole (twice a day for three days)
Trial: 31841482
Drug: Pathogenetic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pathogenetic treatment of the digestive tract
Trial: 23981904
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g CaHMB consumed twice daily
Trial: 19533025
Drug: Carmustine (BCNU)
RxNorm normalized name: Carmustine
DrugBank: Carmustine (DB00262)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carmustine (BCNU) and conformal irradiation (dose levels: 66, 72, 78, 84 Gy)
Trial: 17276051
Drug: 100 mcg
RxNorm normalized name: Levo-T 100 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mcg levosalbutamol
Trial: 17276051
Drug: 200 mcg
RxNorm normalized name: CrM 200 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mcg salbutamol
Trial: 9272426
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg estradiol valerate combined with 75 micrograms levonorgestrel
Trial: 9272426
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg medroxyprogesterone acetate (MPA)
Trial: 30975196
Drug: Curcumin 500-mg
RxNorm normalized name: curcumin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin 500-mg capsule three times daily
Trial: 30975196
Drug: Diclofenac 50-mg
RxNorm normalized name: diclofenac sodium 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 50-mg tablet two times daily
Trial: 16172147
Drug: Two etonogestrel
RxNorm normalized name: Etonogestrel
DrugBank: Etonogestrel (DB00294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Two etonogestrel rods (204 mg etonogestrel) and 400 mg testosterone decanoate every 4 weeks (group I, n = 42)